NASDAQ: BLTE
Belite Bio Inc Stock Ownership - Who owns Belite Bio?

Insider buying vs selling

Have Belite Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BLTE insiders and whales buy or sell their stock.

BLTE Shareholders

What type of owners hold Belite Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
State Street Corp0.06%20,203$1.35MInstitution
Geode Capital Management LLC0.04%12,864$857.13kInstitution
Marshall Wace LLP0.03%9,486$632.05kInstitution
Citadel Advisors LLC0.02%7,456$496.79kInstitution
Jpmorgan Chase Co0.02%6,757$450.22kInstitution
Renaissance Technologies LLC0.01%4,300$286.51kInstitution
Bnp Paribas Financial Markets0.01%3,291$219.28kInstitution
Cubist Systematic Strategies LLC0.01%2,874$191.49kInstitution
Eversource Wealth Advisors LLC0.01%2,550$169.91kInstitution
Ubs Group Ag0.01%2,358$157.11kInstitution

1 of 2

BLTE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BLTE0.25%0.00%
HRMY70.49%29.51%Net Selling
SRPT74.06%25.94%Net SellingNet Selling
IDYA92.77%7.23%Net Buying
GLPG48.16%0.00%

Belite Bio Stock Ownership FAQ

Who owns Belite Bio?

Belite Bio (NASDAQ: BLTE) is owned by 0.25% institutional shareholders, 0.00% Belite Bio insiders, and 99.75% retail investors. State Street Corp is the largest individual Belite Bio shareholder, owning 20,203.00 shares representing 0.06% of the company. State Street Corp's Belite Bio shares are currently valued at $1.35M.

If you're new to stock investing, here's how to buy Belite Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.